Preparation and characterization of cyclodextrin nanosponges for bortezomib delivery.

Saeideh Allahyari Hadi Valizadeh Leila Roshangar Mohammad Mahmoudian Francesco Trotta Fabrizio Caldera Mitra Jelvehgari Parvin Zakeri-Milani

Published in: Expert opinion on drug delivery (2020)

CDNS 1:4 has the ability to be introduced as a nontoxic carrier for BTZ delivery with its high loading, controlled release manner, high cellular uptake, and permeability improvement characteristics.

Keyphrases

endothelial cells
newly diagnosed
ionic liquid